1. Afkhamzadehm, A. 2004. Risk factors of vancomycin-resistant enterococci colonization in patients admitted in Namazi hospital-Shiraz 2004. Shiraz: Shiraz University of Medical Sciences.
2. Almeida, R. T., Filho, M., Silveira, R., Rodrigues, C. A. N., Filho, I. P., Nascimento, J. E., Ferreira, R. S., Moraes, II R. F., Boelens, L. M. P., Belkum, H., Felipe, A. V. 2004. Molecular epidemiology and antimicrobial susceptibility of enterococci from Brazilian Intensive Care Units. Braz. J. Infect. Dis. 8:197–205.
3. Arias, C. A, Reyes, J., Zúñiga, M., Cortés, L., Cruz, C., Rico C. L., and D. Panesso on behalf of the Colombian Antimicrobial Resistance Group (RESCOL). 2003. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001–2002. J. Antimicrob. Chemother. 51:59–68.
4. Arthur, M., Reynolds, R., and Courvalin, P. 1996. Glycopeptide resistance in enterococci. Trends Microbiol. 4:401–407.
5. Assadian, O., Askarian, M., Stadler, M., and Shaghaghian, S. 2007. Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran. BMC Infect. Dis. 7:52–56.